Surgery Partners, Inc. (SGRY) Tops Q4 EPS by 7c

Surgery Partners, Inc. (NASDAQ: SGRY) reported Q4 EPS of $0.27, $0.07 better than the analyst estimate of $0.20. Revenue for the quarter came in at $707.1 million versus the consensus estimate of $688.06 million.

GUIDANCE:

Surgery Partners, Inc. sees Q1 2023 revenue of greater than $2.75 billion, versus the consensus of $2.81 billion.

For earnings history and earnings-related data on Surgery Partners, Inc. (SGRY) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• BofA lists top 5 themes driving next $1tn in incremental semi sales
• After-Hours Stock Movers: FDX, CBRS, NKE